Location of Repository

Personalized Prognosis and Diagnosis of Type 2 Diabetes - Vision or Fiction?

By Guenter Mueller

Abstract

Typical civilization diseases, such as type 2 diabetes, share several features: their worldwide frequency, the complexity of the underlying pathogenic mechanisms, heterogeneity in the phenotypes and their multifactorial nature due to a wide variety of possible combinations of disease susceptibility or protective genes in different tissues and negative or positive environmental factors. This is in sharp contrast to classical inherited diseases, such as Huntington's chorea, which are often caused by complete loss- or gain-of-function mutations in a single gene. The causative polymorphisms of susceptibility genes, however, are characterized by relatively subtle alterations in the function of the corresponding gene products, i.e. low penetrance and effect size, which do not support the pathogenesis per se, and by their high frequency; these two characteristics result in high expenditures for their identification and a rather low predictive value. In the future, the reliable and early diagnosis of common diseases will thus depend on the determination of all (or as many as possible) polymorphisms of each susceptibility gene together with the corresponding gene products and the metabolites emerging thereof for each individual. Great hopes are currently associated with systems biology to cover these demands in time (i.e. along the pathogenesis) and space (i.e. in all relevant tissues). Copyright (C) 2010 S. Karger AG, Basel

Topics: Medizin, ddc:610
Publisher: Ludwig-Maximilians-Universität München
Year: 2010
OAI identifier: oai:epub.ub.uni-muenchen.de:16387
Provided by: Open Access LMU

Suggested articles

Preview

Citations

  1. (1994). al: Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.
  2. (2007). Altshuler DM: Copy-number variation and association studies of human disease.
  3. (2000). Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res
  4. (2000). C: EIF2AK3, encoding translation initiation factor 2- kinase 3, is mutated in patients with WolcottRallison syndrome. Nat Genet
  5. (2005). Causation and causal interference in epidemiology.
  6. (1992). Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature
  7. (2008). CM: Type 2 diabetes: new genes, new understanding. Trends Genet
  8. (2006). Collins FS: Human laminopathies: nuclei gone genetically awry. Nat Rev Genet
  9. (1962). Diabetes mellitus: a ‘thrifty’ genotype rendered detrimental by progress?
  10. (2005). et al: Genetic prediction of future type 2 diabetes. PLoS Med
  11. (2006). et al: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet
  12. (2007). et al: Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes
  13. Froguel P: Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
  14. (2007). GI: Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci USA
  15. (1997). GI: Mutation in hepatocyte nuclear factor-1 gene (TCF2) associated with MODY. Nat Genet
  16. (1996). GI: Mutations in the hepatic nuclear factor 1 gene in maturity-onset diabetes of the young (MODY3). Nature
  17. GI: Mutations in the hepatocyte nuclear factor 4 gene in maturity-onset diabetes of the young (MODY1).
  18. (2009). Groop L: Genetic dissection of type 2 diabetes. Mol Cell Endocrinol
  19. (2008). Hatterlsley AT: Learning from molecular genetics. Novel insights arising from the definition of genes for monogenic and type 2 diabetes. Diabetes
  20. (2004). Hattersley AT: Activating mutations in the gene encoding the ATPsensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
  21. (1999). Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell
  22. Hide W: New methods for finding disease-susceptibility genes: impact and potential.
  23. JC: Population-based resequencing of ANGPLT4 uncovers variations that reduce triglycerides and increase HDL.
  24. (1988). M a r c u s - S am u e l s B , K a d o w aki H , B e i t z L, McKeon C, Taylor SI: Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance.
  25. (2007). Mechanisms of disease: genetic insights into the etiology of type 2 diabetes and obesity. Nature Clin Pract
  26. (2006). Njolstad PR: Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet
  27. (1999). O’Rahilly S: Dominant negative mutations in human PPAR associated with severe insulin resistance, diabetes mellitus and hypertension. Nature
  28. One gene, twenty years.
  29. (1998). Polonsky KS: Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1 -deficient mice.
  30. (2007). regulating pancreas development, beta-cell function and growth. Endocr Dev
  31. (2006). S: A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum Mol Genet
  32. (2008). The emerging landscape of breast cancer susceptibility.
  33. (2008). The genetics of type 2 diabetes: a realistic appraisal in
  34. (1999). The hepatic nuclear factor-1 G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree.
  35. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet
  36. The mode of action of glimepiride – beyond insulin secretion. Curr Med Chem
  37. (2004). Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia
  38. (2005). TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet
  39. (1992). Type 2 diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia
  40. (2008). van Duijn CM: Genomebased prediction of common diseases: advances and prospects. Hum Mol Genet
  41. (1992). Wainscoat JS: Linkage of type 2 diabetes to the glucokinase gene. Lancet
  42. (2001). X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.
  43. (2006). Zeggini E, et al: Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.